pharma · Helicobacter Pylori · Type 2 Diabetes
Shandong Jinpharm Co.,Ltd
Shandong University
Shandong University is a pharma organization headquartered in CN. Primary therapeutic focus areas include Helicobacter Pylori, Type 2 Diabetes, Sedation. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and
Linyi, CN HQ
5 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Linyi, CN
- Employees
- 5
- Programs
- 3
- Drugs
- 5
- Patents
- 0
bismuth-containing quadral therapy based on antibiotic susceptibility
Unknown · small molecule · Helicobacter Pylori
bismuth-containing quadral therapy based on antibiotic susceptibility for Helicobacter Pylori is a Unknown program (small_molecule) at Shandong University with 1 ClinicalTrials.gov record(s).
Internal code 2018SDU-QILU-G113
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Shandong University
- Phase
- Unknown
- Modality
- small_molecule
- Indication
- Helicobacter Pylori
- Status
- active
- Trials
- 1